The global deep brain stimulation market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.91% during 2025-2033. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 1.4 Billion |
Market Forecast in 2033
|
USD 2.8 Billion |
Market Growth Rate 2025-2033 | 7.91% |
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson’s disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington’s disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
Deep Brain Stimulation Market Trends:
At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2025-2033. Our report has categorized the market based on stimulation type, product, application, and end-user.
Stimulation Type Insights:
The report has provided a detailed breakup and analysis of the deep brain stimulation market based on the stimulation type. This includes subthalamic DBS, globus pallidus DBS, thalamic DBS, and pedunculopontine nucleus DBS.
Product Insights:
A detailed breakup and analysis of the deep brain stimulation market based on the product has also been provided in the report. This includes single channel deep brain stimulator and dual channel deep brain stimulator. According to the report, dual channel deep brain stimulator accounted for the largest market share.
Application Insights:
A detailed breakup and analysis of the deep brain stimulation market based on the application has also been provided in the report. This includes Parkinson's disease (PD), epilepsy, dystonia, obsessive compulsive disorder (OCD), and others. According to the report, Parkinson's disease (PD) accounted for the largest market share.
End-User Insights:
A detailed breakup and analysis of the deep brain stimulation market based on the end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, neurological centers, and others. According to the report, hospitals accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for deep brain stimulation. Some of the factors driving the North America deep brain stimulation market included the growing investment in the medical sector, rising construction of healthcare facilities, increasing occurrence of various neurological conditions among the masses, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global deep brain stimulation market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Stimulation Types Covered | Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS |
Products Covered | single channel deep brain stimulator, dual channel deep brain stimulator |
Applications Covered | Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), Others |
End-Users Covered | Hospitals, Ambulatory Surgical Centers, Neurological Centers, Others |
Regions Covered | Asia Pacific, North America, Europe, Middle East and Africa, Latin America |
Companies Covered | Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace and Neuro Sigma |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: